Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis.
Saved in:
| Title: | Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. |
|---|---|
| Authors: | Takamatsu M; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan. manabu.takamatsu@jfcr.or.jp.; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. manabu.takamatsu@jfcr.or.jp., Tanaka M; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Masugi Y; Department of Pathology, Keio University School of Medicine, Tokyo, Japan.; Department of Pathology, Tokai University School of Medicine, Kanagawa, Japan., Inoue Y; Division of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Nagano H; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan., Le TN; Department of Pathology, University Medical Center Ho Chi Minh City, Ho Chi Minh City, Vietnam., Nishida K; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Sawa Y; Division of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Sugiura K; Division of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Kawaguchi Y; Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Kazami Y; Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Nakai Y; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.; Department of Internal Medicine, Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan., Hamada T; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. hamada-tky@umin.ac.jp.; Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. hamada-tky@umin.ac.jp., Suzuki T; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Hara K; Department of Pathology, Keio University School of Medicine, Tokyo, Japan., Kurebayashi Y; Department of Pathology, Keio University School of Medicine, Tokyo, Japan., Takeda T; Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Sasahira N; Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Uematsu Y; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Uemura S; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Fujishiro M; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Hasegawa K; Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Kitago M; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Takahashi Y; Division of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Sekine S; Department of Pathology, Keio University School of Medicine, Tokyo, Japan., Ushiku T; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Takeuchi K; Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.; Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan. |
| Corporate Authors: | GTK Pancreatic Cancer Study Group in Japan |
| Source: | British journal of cancer [Br J Cancer] 2026 Mar; Vol. 134 (6), pp. 849-859. Date of Electronic Publication: 2026 Jan 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
